Abstract：Endometrial cancer accounts for 20%-30% of malignant tumors of the female reproductive system. Since 2008, endometrial cancer has become the most common malignant tumor in the female genital tract, and in 2012, it ranked the 5th among female malignant tumors. Different from gastrointestinal cancer, endometrial cancer has a low incidence of cachexia. On the contrary, About 68% of patients with early-stage endometrial cancer were obese, with higher rates of obesity or overweight. Obese endometrial cancer patients were more likely to be associated with metabolic diseases, which increased the risk of death. Obese patients with endometrial cancer had a higher incidence of surgery-related complications. Abnormal chemotherapeutic drug metabolism affects the efficacy of obese endometrial cancer patients. Therefore, individualized nutritional assessment and nutritional intervention in patients with endometrial cancer should be paid more attention.
中国抗癌协会肿瘤营养专业委员会 . 子宫内膜癌患者的营养治疗专家共识[J]. 肿瘤代谢与营养电子杂志, 2020, 7(4): 415-417.
Chinses Society of Nutritional Oncology. Expert consensus on nutritional therapy for patients with endometrial cancer. Electron J Metab Nutr Cancer, 2020, 7(4): 415-417.
1.PAPATLA K, HUANG M, SLOMOVITZ B. The obese endometrial cancer patient: how do we effectively improve morbidity and mortality in this patient population?［J］. Ann Oncol, 2016, 27(11): 1988-1994.
2.SIEGEL RL, MILLER, KIMBERLY D, et al. Cancer statistics, 2017［J］. CA CANCER J CLIN, 2017, 67(1):7-30.
3.ARNOLD M, JIANG L, STEFANICK ML, et al. Duration of Adulthood Overweight, Obesity, and Cancer Risk in the Women’s Health Initiative: A Longitudinal Study from the United States［J］. PLoS Med, 2016, 13(8): e1002081.
4.陈万青, 张思维, 曾红梅,等．中国2010年恶性肿瘤发病与死亡［J］．中国肿瘤,2014,23(1):l-10．
5.National Cancer center,Ministry or health disease prevention and control bureau．annual Chinese cancer registry of 201l［M］．Beijing:Military Medical Academy Press,2012:1-216．
6.廖秦平, 杨曦. 子宫内膜癌筛查及早期诊断的现状及展望［J］．实用妇产科杂志, 2015, 31(7):481-484．
7.KOVALEV S, MARCHENKO ND, GUGLIOTTA BG, et al. Loss of p53 function in uterine papillary serous carcinoma［J］. Hum Pathol, 1998, 29:613-619.
8.CAO QJ, BELBIN T, SOCCI N, et al. Distinctive gene expression profiles by cDNA microarraysinendometrioid and serous carcinomas of the endometrium［J］. Int J Gynecol Pathol, 2004, 23:321-329.
9.WATSON P, LYNCH H. Extracolonic cancer in hereditary nonpolyposis colorectal cancer［J］. Cancer, 1993, 71:677-685.
10.VIVIAN EG, KERRY SC, HEIDI EG, et al. Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: A randomized trial［J］. Gynecol Oncol, 2008, 109:19-26.
11.EUGENIA EC, CARMEN R, KIMBERLY WT, et al. Overweight, obesity and mortality from cancer in a prospectively studies of U.S. adult［J］. N Engl J Med, 2003, 348:1625-1638.
12.KERRY SC, KRISTINA HK, KRISTIN LC, et al. Association among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors［J］. Gynecol Oncol, 2005, 97:422-430.
13.OBERMAIR A, SIMUNOVIC M, ISENRING L, et al. Nutrition interventions in patients with gynecological cancers requiring surgery［J］. Gynecol Oncol, 2017, 145(1):192-199.
14.HAGEMANN AR, MCCOURT CK, VARADAY SS, et al. Defining and mitigating the challenges of an older and obese population in minimally invasive gynecologic cancer surgery［J］. Gynecol Oncol, 2018, 148(3):601-608.
15.LASKEY R, MCCARROLL ML, VON GRUENIGEN VE. Obesity-related endometrial cancer: an update on survivorship approaches to reducing cardiovascular death［J］. BJOG, 2016, 123(2):293-298.
16.EVERETT E, TAMIMI H, GREER B, et al. The effect of body index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer［J］. Gynecol Oncol, 2003, 90(1):150-157.
17.WARD KK, SHAH NR, SAENZ CC, et al. Cardiovascular disease is the leading cause of death among endometrial cancer patients［J］. Gynecol Oncol, 2012, 126(2):176-179.
18.COURNEYA KS, KARVINEN KH, CAMPBELL KL, et al. Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors［J］. Gynecol Oncol, 2005, 97(2): 422-430.
19.IJAZ S, YANG W, WINSLET MC, et al. Impairment of hepatic microcirculation in fatty liver［J］. Microcirculation. 2003,10(6): 447-456.
20.SPARREBOOM A, WOLFF AC, MATHIJSSEN RHJ, et al. Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese［J］. J Clin Oncol, 2007, 25(30):4707-4713.
21.HOROWITZ NS, WRIGHT AA. Impact of obesity on chemotherapy management and outcomes in women with gynecologic malignancies［J］. Gynecol Oncol, 2015, 138(1):201-206.
22.PATEL AV, FEIGELSON HS, TALBOT JT, et al. The role of body weight in therelationship between physical activity and endometrial cancer: Results from a large cohort of US women［J］. Int J Cancer, 2008, 123(8):1877-1882.
23.. CHERY LR, COLLEEN D, WENDY W, et al. Nutrition and physical activity guidelines for cancer survivors［J］.CA Cancer J Clin. 2012, 62(4):275-276.
24.ALICE HL, LAWRENCE JA, MICHAEL B, et al. Diet and lifestyle recommendations revision 2006. A scientific statement from the American Heart Association Nutrition Committee［J］. Circulation, 2006, 114:82-96.
25.ALEXANDAR RL, BRAIN CF, DAVID EC, et al. A mindfulness-based lifestyle intervention for obese, inactive endometrial cancer survivors: A feasibility study［J］. Integr Cancer Ther, 2017, 16(3):263-275.
